Cargando…

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction

OBJECTIVE: To develop gene expression profiles that characterise KRAS-, BRAF- or PIK3CA-activated- tumours, and to explore whether these profiles might be helpful in predicting the response to the epidermal growth factor receptor (EGFR) pathway inhibitors better than mutation status alone. DESIGN: F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Sun, Simon, Iris, Moreno, Victor, Roepman, Paul, Tabernero, Josep, Snel, Mireille, van't Veer, Laura, Salazar, Ramon, Bernards, Rene, Capella, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2013
Materias:	Colon
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596735/ https://www.ncbi.nlm.nih.gov/pubmed/22798500 http://dx.doi.org/10.1136/gutjnl-2012-302423

Ejemplares similares

Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium
por: Fennell, Lochlan, et al.
Publicado: (2022)

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
por: Derbel, Olfa, et al.
Publicado: (2013)

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
por: Mangiapane, Laura Rosa, et al.
Publicado: (2022)

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model
por: Meester, Reinier G S, et al.
Publicado: (2023)

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
por: Møller, Pål, et al.
Publicado: (2017)

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
por: Møller, Pål, et al.
Publicado: (2017)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
por: Ferrer-Mayorga, Gemma, et al.
Publicado: (2017)

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
por: Møller, Pål, et al.
Publicado: (2018)

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
por: Vuik, Fanny ER, et al.
Publicado: (2019)

ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
por: Segelov, Eva, et al.
Publicado: (2016)

Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study
por: van Heijningen, Else-Mariëtte B, et al.
Publicado: (2015)

Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study
por: Bleijenberg, Arne GC, et al.
Publicado: (2020)

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
por: Roepman, Paul, et al.
Publicado: (2014)

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres
por: Jones, A M, et al.
Publicado: (2011)

Performance measures in three rounds of the English bowel cancer screening pilot
por: Moss, S M, et al.
Publicado: (2011)

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population
por: Cui, R, et al.
Publicado: (2011)

Colorectal cancer screening with odour material by canine scent detection
por: Sonoda, Hideto, et al.
Publicado: (2011)

Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer
por: Betts, Gareth, et al.
Publicado: (2011)

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models
por: Hackl, Christina, et al.
Publicado: (2013)

miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer
por: Ji, Shunlong, et al.
Publicado: (2013)

Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation
por: Lourenço, Filipe C, et al.
Publicado: (2014)

Source of dietary fibre and diverticular disease incidence: a prospective study of UK women
por: Crowe, Francesca L, et al.
Publicado: (2014)

Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)
por: Puthia, Manoj, et al.
Publicado: (2014)

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
por: Church, Timothy Robert, et al.
Publicado: (2014)

Canonical Wnt signals combined with suppressed TGFβ/BMP pathways promote renewal of the native human colonic epithelium
por: Reynolds, Amy, et al.
Publicado: (2014)

Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines
por: Davis, Hayley, et al.
Publicado: (2014)

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
por: Yu, Jun, et al.
Publicado: (2015)

Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme
por: Lo, Siu Hing, et al.
Publicado: (2015)

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
por: Rosmarin, Dan, et al.
Publicado: (2015)

Initial US evaluation of second-generation capsule colonoscopy for detecting colon polyps
por: Morgan, Douglas R, et al.
Publicado: (2016)

The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon
por: Grimm, Wesley A, et al.
Publicado: (2016)

Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer
por: Xu, Lixia, et al.
Publicado: (2016)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Low-residue breakfast during the preparation for colonoscopy using a polyethylene glycol electrolyte solution: a randomised non-inferiority trial
por: Flemming, Jennifer A, et al.
Publicado: (2015)

Severe colic mimicking intussusception: a new phenomenon
por: El-Gohary, Mohamed Amin
Publicado: (2015)

Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program
por: Chiu, Sherry Yueh-Hsia, et al.
Publicado: (2017)

Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C
por: Müller, Thomas, et al.
Publicado: (2016)

Randomised clinical study comparing the effectiveness and physiological effects of hypertonic and isotonic polyethylene glycol solutions for bowel cleansing
por: Yamano, Hiro-o, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v9sp4n03mnto67blcdkpcc6kdv